Clinical Implication of Sarcopenia in Patients with Acute Decompensated Heart Failure: Design and Rationale
Authors:
Open Access
- 3 September 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (1) , 640-648
Abstract
Background: Sarcopenia is widely recognized as an age-related syndrome that involves a progressive loss of skeletal muscle mass and muscle strength. Many studies have shown that sarcopenia is associated with disease severity and exercise intolerance, as well as an independent predictor of mortality in patients with chronic heart failure. However, there is little research on the impact of sarcopenia on patients hospitalized with acute decompensated heart failure (ADHF). Methods: This is a prospective, multicentre, observational cohort study. Enrolment of at least 500 participants adults aged over 18 years hospitalized for ADHF is planned, with a minimum of 195 cases each for patients with and without sarcopenia. Each patient is followed up for 6 months, 1 year, 2 years or until the occurrence of endpoint. The primary clinical outcome is all-cause mortality at 6 months. Other clinical outcomes of interest include cardiovascular mortality, all-cause hospitalization, heart failure hospitalization and survival time from enrolment to event occurrence. The sympathetic nervous activity, psychosocial factors, quality of life, physical function, and physical activity will be assessed and recorded at baseline. This study will examine the correlation between sarcopenia and prognosis in different subgroups of patients, and explore the additive effect of different comorbidities and sarcopenia on prognosis in patients with ADHF. Conclusions: This study will provide important information and evidence on the clinical aspects of sarcopenia in patients with ADHF, potentially contributing to accurate risk stratification and optimal clinical management for patients with ADHF. REGISTRATION: (URL: https://www.clinicaltrials.gov); Unique identifier: NCT06298825.Keywords
Funding Information
- Guangdong Provincial People's Hospital (DFJH201922)
- Guangdong Provincial People's Hospital (DFJH2020029)
- Guangzhou Municipal Science and Technology Program key projects (2023B03J1249)
- Guangdong Provincial People's Hospital (DFJH201922)
- Guangdong Provincial People's Hospital (DFJH2020029)
- Guangzhou Municipal Science and Technology Program key projects (2023B03J1249)
This publication has 45 references indexed in Scilit:
- Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta‐analysis and systematic reviewClinical Cardiology, 2023
- Baseline Characteristics of Patients in the PARALLAX Trial: Insights Into Quality of Life and Exercise Capacity in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2021
- Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection FractionJAMA Cardiology, 2021
- Sarcopenia in Heart Failure: A Systematic Review and Meta-AnalysisESC Heart Failure, 2021
- Loss of Skeletal Muscle Mass Predicts Cardiac Death in Heart Failure with a Preserved Ejection Fraction but not Heart Failure with a Reduced Ejection FractionESC Heart Failure, 2020
- Muscle wasting as an independent predictor of survival in patients with chronic heart failureJournal of Cachexia, Sarcopenia and Muscle, 2020
- Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetesJournal of Cachexia, Sarcopenia and Muscle, 2019
- Malnutrition and sarcopenia predict post‐liver transplantation outcomes independently of the Model for End‐stage Liver Disease scoreJournal of Cachexia, Sarcopenia and Muscle, 2016
- The 30-Day Metric in Acute Heart Failure Revisited: Data from in-Hf Outcome, an Italian Nationwide Cardiology RegistryEuropean Journal of Heart Failure, 2015
- Developing Consensus Criteria for Sarcopenia: An UpdateJournal of Bone and Mineral Research, 2015